Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings - Wikidata - awgldk - TriplyDB

Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings

Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings

http://www.wikidata.org/entity/Q28475627

about

Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis Evaluating New Definitions of Acute and Early HIV Infection from HIV Surveillance Data.The detection and management of early HIV infection: a clinical and public health emergency.HIV transmission rate modeling: a primer, review, and extension.Screening acute HIV infections among Chinese men who have sex with men from voluntary counseling & testing centers.Targeting the use of pooled HIV RNA screening to reduce cost in health department STD clinics: New York City, 2009-2011.Finding those at risk: acute HIV infection in Newark, NJ.Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco Towards targeted screening for acute HIV infections in British Columbia Enhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay.Integrating acute HIV infection within routine public health surveillance practices in New York City.HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men.Using a Multitest Algorithm to Improve the Positive Predictive Value of Rapid HIV Testing and Linkage to HIV Care in Nonclinical HIV Test Sites.The HIV treatment cascade in acutely infected people: informing global guidelines.Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi.Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States.The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA.HIV testing strategies: test performance is important, but not sufficient.Diagnosing acute HIV infection.Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011.A systematic review on cost effectiveness of HIV prevention interventions in the United States.Evaluation of pooling strategies for acute HIV-1 infection screening using nucleic acid amplification testing.Clinical and public health implications of acute and early HIV detection and treatment: a scoping review.Improved matrix pooling.Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions.HIV testing: current practice and future directions.Cost-effectiveness of nucleic acid amplification tests for identifying acute HIV infections Targeting screening and social marketing to increase detection of acute HIV infection in men who have sex with men in Vancouver, British Columbia.Cost-effectiveness of a fourth-generation combination immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen for the detection of HIV infections in the United States.Rapid HIV screening: missed opportunities for HIV diagnosis and prevention.How much should we pay for a new HIV diagnosis? A mathematical model of HIV screening in US clinical settings.Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

P2860

Q24607025-F473A7B3-A4E4-437C-A6B2-265C52AEB001 Q27318250-385E3013-A70D-4BCF-A165-C063456E8BE5 Q28478017-184AF59D-EB56-40F4-8CDB-06E642D2F11F Q30860373-C3BA67DF-586F-4EA3-9B6A-944F6B260B96 Q33586581-8108889B-9B5D-4070-A20F-77808702C8E4 Q33918388-B3176521-2D37-415A-8425-544C53120126 Q34110368-6BE424B7-8C13-41F9-91F8-1101D4C2A128 Q34576775-E1F27904-62AE-468A-81A7-F815B7E98C72 Q34701577-5EEC110C-EA41-4ED1-AB9B-E46DF42F0039 Q35069399-A26F35E3-401A-4657-A4D0-21CEEC46074B Q35203643-D36D70E5-C2AF-4AB6-9E4B-553C787CD337 Q35542113-06DCB970-B718-41F4-B21B-8D915BE48EB9 Q36005278-A050DB76-3E35-4946-BA18-48B9B58CAF7C Q36084431-2264A4C3-17C1-4201-AB82-B8A3BA4D6424 Q36507685-5FA23407-2A03-49C7-9B02-36F966F88975 Q36539990-72889C6F-EE68-43BF-ACB0-D8A8C21BF20C Q36576458-9EC55A34-08B9-4AD9-A64F-839320D217A7 Q36628388-30AB73C3-B30B-4ED5-BE38-E0A545A82843 Q36854378-F63242D9-B8DC-4DEC-B48B-A1F248036C2C Q37845848-F8304B44-7B4C-432C-9479-C11BFA245B53 Q37965692-385FEAA2-00A9-43F8-9408-46F7B7AA3024 Q38114141-EFBC6FF5-7145-4424-BFFF-18BCDAE122F4 Q38299227-C7A7E6D3-A00B-4455-88C2-C4099A337BBD Q38630017-8724AF33-D061-436A-94C1-984E2593C463 Q38686953-84C9606A-094C-4529-835B-AF506551C94D Q38849316-3A4F0CD2-8199-47C1-AF1A-938F0B0BC499 Q39070385-E5091089-B468-438A-A8F4-6CB6CF807D9B Q39445877-4B3AA97A-52DE-4634-91BE-61E133A39765 Q42773357-087E853B-549D-46E9-91B3-F3472552AFF0 Q42925387-0B98DBE8-B926-425D-B2E3-C98A0FD7F204 Q45359891-3301C385-FE42-4D2B-BDA7-1BF36B9F8EC3 Q46462542-61A211C8-6EFC-4947-9078-78489763D4DD Q51175993-59AB8B96-BB64-460A-8A9C-2E83A27DB5DE Q54219902-9F70895A-164A-4748-BD5D-CABE0702D362 Q57178901-651706CD-D23A-43F7-B9CE-6E75D045E594

P2860

Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings

http://www.wikidata.org/entity/Q28475627

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cost-effectiveness of pooled n ...... f three public health settings

@ast

Cost-effectiveness of pooled n ...... f three public health settings

@en

Cost-effectiveness of pooled n ...... f three public health settings

@nl

type

label

Cost-effectiveness of pooled n ...... f three public health settings

@ast

Cost-effectiveness of pooled n ...... f three public health settings

@en

Cost-effectiveness of pooled n ...... f three public health settings

@nl

prefLabel

Cost-effectiveness of pooled n ...... f three public health settings

@ast

Cost-effectiveness of pooled n ...... f three public health settings

@en

Cost-effectiveness of pooled n ...... f three public health settings

@nl

P1433

Q28475627-625790C4-B50A-4505-B99B-F7EF55245527

P1476

Q28475627-334E8C72-BADE-4B79-A712-0598A3DE10EE

P2093

Q28475627-02B9E203-502E-45B6-9927-E9108FF31CFC

Q28475627-0E31D471-403E-4ADA-8C64-F17586EC41AD

Q28475627-87446ED0-BDFB-4A65-ABD2-4335E75E060A

Q28475627-A61609F1-9519-4119-A62A-162A357D1F7D

Q28475627-AE4BC672-DEE4-4E74-9A97-69C827E28D2C

Q28475627-BA79D939-0EFE-4E7F-B029-30A61AC8456E

Q28475627-C8D81E2E-BB45-462E-942C-4FE2D3A94229

Q28475627-F2F44F5F-C785-4759-8030-6F2B3B223A79

Q28475627-F6A9EAB2-FC07-4C7C-90D0-10E1E5D7B69A

Q28475627-F9789DE9-FB3D-4B97-AF9D-94E5AA67A90D

P2860

Q28475627-15E14EF0-0B60-4BFF-80C9-D5F99E12036B

Q28475627-2BC426FC-1CA1-42D1-89FC-AA29E6688296

Q28475627-322DC861-AABE-4C78-A983-06D230519CBD

Q28475627-3ED19895-B1B6-40C7-916A-F6703CF09DA5

Q28475627-45D3FB30-24DC-4A5D-AC92-37E74FCDE7A6

Q28475627-49A6A793-2698-4C63-8CA0-2CFF1D0FF5B0

Q28475627-51848859-9143-49EF-ACCD-D478B866DB2E

Q28475627-52108EDE-1439-47B6-B52F-DF411CF8ED93

Q28475627-537949AB-41CE-49FB-8588-DC36A8EDF26B

Q28475627-62B804CD-9873-4907-ABE8-AF95D27E4751

P304

Q28475627-417E4A86-B2C9-4D1C-97A7-A889782D3A35

P31

Q28475627-05A4C0E7-9995-433A-B7A2-062C366B6E27

P356

Q28475627-7E311A98-3957-4095-A57D-CFD4E9AA9212

P407

Q28475627-89738662-25C1-4293-B131-19FA803A19A6

P433

Q28475627-BFD617D8-F238-4087-8B1D-11C9DD292118

P478

Q28475627-E2FF1381-C2A2-4FCD-8C6E-BB661E031118

P577

Q28475627-99797FA1-88E7-4778-A759-908B4828056D

P5875

Q28475627-150AE4A5-08A9-44F2-9B62-A9A8203714E7

P698

Q28475627-50084984-45CB-4803-8571-6AA13EBAE072

P921

Q28475627-2F0A7948-3EF0-4503-B65C-15A522ACA576

Q28475627-F2DD88A5-BECE-42BC-B1E6-22CF88E62756

P932

Q28475627-55FFBE36-4DCA-4DB9-A7AC-24CECF4F8FB8

P356

JOURNAL.PMED.1000342

P1433

P1476

Cost-effectiveness of pooled n ...... f three public health settings

@en

P2093

Angela B Hutchinson

http://www.w3.org/2001/XMLSchema#string

Bernard M Branson

http://www.w3.org/2001/XMLSchema#string

Berry Bennett

http://www.w3.org/2001/XMLSchema#string

James D Heffelfinger

http://www.w3.org/2001/XMLSchema#string

Paul G Farnham

http://www.w3.org/2001/XMLSchema#string

Peter R Kerndt

http://www.w3.org/2001/XMLSchema#string

Pragna Patel

http://www.w3.org/2001/XMLSchema#string

Robert K Bolan

http://www.w3.org/2001/XMLSchema#string

Stephanie L Sansom

http://www.w3.org/2001/XMLSchema#string

Timothy J Sullivan

http://www.w3.org/2001/XMLSchema#string

P2860

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

Deaths: final data for 2005.

Targeted testing for acute HIV infection in North Carolina.

Estimation of HIV incidence in the United States.

Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008.

Revised guidelines for HIV counseling, testing, and referral.

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

What is the price of life and why doesn't it increase at the rate of inflation?

HIV testing in a high-incidence population: is antibody testing alone good enough?

Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals.

P304

e1000342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1000342

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47358133

http://www.w3.org/2001/XMLSchema#string

P698

20927354

http://www.w3.org/2001/XMLSchema#string

P921

P932

2946951

http://www.w3.org/2001/XMLSchema#string